Article
XIAP as target for therapeutic apoptosis in prostate cancer
1 Jan 2004
Abstract excerpt
Progression to androgen independence combined with chemotherapy resistance remains one of the primary obstacles to the improvement of quality of life and survival for patients with advanced prostate cancer. One unique feature of the androgen-independent cell population is that they still retain the appropriate machinery for apoptosis. Therefore, identifying a cure for prostate cancer requires identification and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
